Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | RANGE IMPACT, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
26.04. | Range Impact, Inc.: Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer | 1 | GlobeNewswire (USA) | ||
26.04. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
29.03. | Range Impact reports Q4 results | 1 | Seeking Alpha | ||
29.03. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
29.03. | RANGE IMPACT, INC. - 10-K, Annual Report | - | SEC Filings | ||
29.03. | Range Impact, Inc.: Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results | 88 | GlobeNewswire (Europe) | CLEVELAND, OHIO, March 29, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact"), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites... ► Artikel lesen | |
29.01. | Range Impact, Inc.: Range Impact Announces Former Ohio Congressman Zack Space and Former Ohio Senator Jay Hottinger Have Joined the Company as Strategic Advisors | 1 | GlobeNewswire (USA) | ||
21.12.23 | Range Impact, Inc.: Range Impact Announces $1.7 Million Capital Raise Led by Strategic Investors | 1 | GlobeNewswire (USA) | ||
14.12.23 | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
14.12.23 | Malachite Innovations changes name to Range Impact | 1 | Seeking Alpha | ||
14.12.23 | Malachite Innovations, Inc.: Malachite Innovations Changes its Name to Range Impact and Adopts New Ticker Symbol "RNGE" | 259 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Malachite Innovations, Inc. announces that it has changed its name to Range Impact, Inc. ("Range Impact") and adopted a new ticker symbol "RNGE"... ► Artikel lesen | |
07.12.23 | Malachite Innovations, Inc.: Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business | 1 | GlobeNewswire (USA) | ||
14.11.23 | Malachite Innovations reports Q3 results | 1 | Seeking Alpha | ||
01.08.23 | Malachite Innovations, Inc.: Malachite Innovations Reports Second Quarter 2023 Results | 303 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 01, 2023 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) ("Malachite"), a public company focused on improving the health and wellness of people and the planet... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 119,76 | +0,91 % | Märkte am Morgen: Baidu, Nio, Apple, Moderna, Daimler Truck, Novo Nordisk, PBB, LVMH, ASML, Nordex | Der DAX hat sich gestern nach dem Feiertag wenig bewegt präsentiert. Letzen Endes schloss der DAX 0,2 Prozent tiefer bei 17.896 Punkten. Heute könnte es bereits wieder nach oben gehen. Die Vorgaben... ► Artikel lesen | |
AURORA CANNABIS | 6,015 | 0,00 % | Nach Aurora, Canopy und Tilray: Diese Cannabis-Aktie ist superheiß | Die Cannabis-Branche hat zuletzt neue Impulse vom Rescheduling in den USA sowie die Freigabe in Deutschland erhalten. Vor diesem Hintergrund ging es für zahlreiche Cannabis-Player teils zweistellig... ► Artikel lesen | |
CANOPY GROWTH | 8,460 | +0,24 % | Canopy Growth, Globex Mining und Rock Tech Lithium mit starken Signalen | Nachdem sich die Edelmetalle Gold und Silber nach einer Rally eine Verschnaufpause gönnen, rücken andere Märkte in das Zentrum des Anlegerinteresses. Neben Kupfer, dass aufgrund der Angebotsknappheit... ► Artikel lesen | |
TILRAY BRANDS | 1,806 | +0,50 % | Tilray Brands stock price analysis: TLRY is extremely risky, avoid | ||
VERTEX PHARMACEUTICALS | 392,30 | -0,08 % | Vertex Pharmaceuticals Inc. Q1 Profit Increases, beats estimates | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) reported a profit for its first quarter that increased from last year and beat the Street estimates.The company's bottom... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,136 | -19,10 % | TAAT Global Alternatives Inc (2): SEC charges Alomari, aka "GMoney," for on-line touting | ||
CRONOS GROUP | 2,556 | -0,78 % | Cronos Group Inc.: Cronos Group Reports 2024 First Quarter Results | Industry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year to $25.3 million Spinach® was top-3 in retail sales in... ► Artikel lesen | |
DIGICANN VENTURES | 0,011 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 26.01.2024 | The following instruments on XETRA do have their first trading 26.01.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.01.2024
Aktien
1 KYG7006A1094 Perfect Corp.
2 JP3501950004... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 11,155 | -0,54 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU in Non-Proliferative Diabetic Retinopathy | - DURAVYU demonstrates stable or improved disease severity with reduced rates of NPDR progression at nine months - - DURAVYU continues to demonstrate favorable safety and tolerability profile with... ► Artikel lesen | |
SANOCHEMIA PHARMAZEUTIKA | - | - | Nachlese: Magnus Brunner vs. FMA" EOSS holt nach Sanochemia auch BDI BioEnergy; Bettina Pfluger (Christian Drastil) | Um 12:12 liegt der ATX mit +0.03 Prozent im Plus bei 3452 Punkten (Ultimo 2023: 3435, 0.49% ytd). Topperformer der PIR-Group sind Addiko Bank mit +1.82% auf 15.425 Euro, dahinter DO&CO mit +1.79% auf... ► Artikel lesen | |
ORGANIGRAM | 1,644 | +0,86 % | Organigram Holdings Inc (2): Organigram to release fiscal Q2 2024 results May 14 | ||
GREEN THUMB INDUSTRIES | 11,850 | -1,17 % | Neuer Gesetzesentwurf!: Kommt nach der Cannabis-Neuregulierung nun eine komplette Legalisierung in USA?! | ||
MYDECINE INNOVATIONS GROUP | 0,009 | 0,00 % | Mydecine Innovations Group Inc - Mydecine applies for management cease trade order | Mydecine Innovations Group Inc - Mydecine applies for management cease trade order
PR Newswire
LONDON, United Kingdom, May 03
MYDECINE APPLIES FOR MANAGEMENT CEASE TRADE... ► Artikel lesen | |
ASTRIA THERAPEUTICS | 9,500 | +4,97 % | Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported... ► Artikel lesen | |
SANTHERA PHARMACEUTICALS | 9,371 | -2,48 % | Santhera Pharmaceuticals Holding AG: Santhera gibt vorläufige ungeprüfte Jahresergebnisse 2023 und ein Business-Update bekannt, gefolgt von der Publikation des Jahresberichts im Mai | Ad-hoc-Mitteilung gemäss Art. 53 KR
Eine Telefonkonferenz findet am 25. April 2024 um 14:30 MESZ / 13:30 BST / 08:30 EDT statt. Einzelheiten dazu am Ende dieser Pressemitteilung.
2023 finanzielle... ► Artikel lesen |